Showing results (121-130 of 283) with videos related to
Sort By:
Pageof 29
The Journal of Biological Chemistry|July 15, 2000
Regulation of brain fatty acid-binding protein expression by differential phosphorylation of nuclear factor I in malignant glioma cell linesD A Bisgrove, E A Monckton, M Packer, et al.Journal of the American College of Cardiology|February 1, 1995
Effect of long-term digoxin therapy on autonomic function in patients with chronic heart failureH Krum, J T Bigger, R L Goldsmith, et al.Neurophotonics|January 26, 2026
Desensitization of opsin responses during all-optical interrogation depends on imaging parametersBlake Russell, Robert M Lees, Armin Lak, et al.The American Journal of Cardiology|November 1, 1981
Provocation of myocardial ischemic events during initiation of vasodilator therapy for severe chronic heart failure. Clinical and hemodynamic evaluation of 52 consecutive patients with ischemic cardiomyopathyM Packer, J Meller, N Medina, et al.American Heart Journal|July 1, 1996
Importance of assessing changes in ventricular response to atrial fibrillation during evaluation of new heart failure therapies: experience from trials of flosequinanB M Massie, N B Shah, B Pitt, et al.Acute Medicine|November 20, 2020
Acute, non-COVID related medical admissions during the first wave of COVID-19: A retrospective comparison of changing patterns of diseaseB Riley, M Packer, S Gallier, et al.Journal of the American College of Cardiology|June 1, 1989
Prognostic importance of atrial natriuretic peptide in patients with chronic heart failureS S Gottlieb, M L Kukin, D Ahern, et al.Circulation|September 1, 1981
Determinants of drug response in severe chronic heart failure. 1. Activation of vasoconstrictor forces during vasodilator therapyM Packer, J Meller, N Medina, et al.Cerebral Cortex (New York, N.Y. : 1991)|September 4, 2012
Axo-dendritic overlap and laminar projection can explain interneuron connectivity to pyramidal cellsAdam M Packer, Daniel J McConnell, Elodie Fino, et al.Clinical Pharmacology and Therapeutics|March 1, 1980
Hemodynamic evaluation of hydralazine dosage in refractory heart failureM Packer, J Meller, N Medina, et al.Pageof 29